INVO Bioscience Inc (INVO)
0.9249
-0.01
(-0.66%)
USD |
NASDAQ |
May 03, 16:00
0.92
0.00 (0.00%)
After-Hours: 20:00
INVO Bioscience Debt to Equity Ratio: 3.096 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 3.096 |
September 30, 2023 | 7.504 |
June 30, 2023 | -0.6062 |
March 31, 2023 | 12.45 |
December 31, 2022 | -0.7801 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.1312 |
June 30, 2021 | 0.0573 |
March 31, 2021 | 0.0613 |
December 31, 2020 | 0.1208 |
September 30, 2020 | -0.1961 |
June 30, 2020 | -0.2773 |
March 31, 2020 | -0.0913 |
December 31, 2019 | -0.0955 |
Date | Value |
---|---|
September 30, 2019 | -0.0808 |
June 30, 2019 | -0.0912 |
March 31, 2019 | -0.0788 |
December 31, 2018 | -0.1452 |
September 30, 2018 | -0.0894 |
June 30, 2018 | -0.0898 |
March 31, 2018 | -0.0698 |
December 31, 2017 | -0.0686 |
September 30, 2017 | -0.0702 |
June 30, 2017 | -0.0713 |
March 31, 2017 | -0.0727 |
December 31, 2016 | -0.0764 |
September 30, 2016 | -0.0812 |
June 30, 2016 | -0.0535 |
March 31, 2016 | -0.0561 |
December 31, 2015 | -0.0588 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.7801
Minimum
Dec 2022
12.45
Maximum
Mar 2023
1.116
Average
--
Median
Dec 2021
Debt to Equity Ratio Benchmarks
Abbott Laboratories | 0.3803 |
Perspective Therapeutics Inc | 0.0229 |
Xtant Medical Holdings Inc | 0.4243 |
Asensus Surgical Inc | 0.00 |
Catheter Precision Inc | 0.0087 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 20.89M |
Total Liabilities (Quarterly) | 20.00M |
Shareholders Equity (Quarterly) | 0.8928M |
Current Ratio | 0.1533 |
Net Debt Paydown Yield | -16.43% |